261 related articles for article (PubMed ID: 30742714)
1. Validation of post-treatment PET-based dosimetry software for hepatic radioembolization of Yttrium-90 microspheres.
Maughan NM; Garcia-Ramirez J; Arpidone M; Swallen A; Laforest R; Goddu SM; Parikh PJ; Zoberi JE
Med Phys; 2019 May; 46(5):2394-2402. PubMed ID: 30742714
[TBL] [Abstract][Full Text] [Related]
2. Validation of a commercial software dose calculation for Y-90 microspheres.
Guerrero M; Yao W; Lin M; Becker SJ; Molitoris JK; Vedam S; Yi B
Brachytherapy; 2022; 21(4):561-566. PubMed ID: 35537917
[TBL] [Abstract][Full Text] [Related]
3. 90Y PET-based dosimetry after selective internal radiotherapy treatments.
D'Arienzo M; Chiaramida P; Chiacchiararelli L; Coniglio A; Cianni R; Salvatori R; Ruzza A; Scopinaro F; Bagni O
Nucl Med Commun; 2012 Jun; 33(6):633-40. PubMed ID: 22407156
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of imaging
Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM
Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282
[TBL] [Abstract][Full Text] [Related]
5. PET-CT post therapy dosimetry in radioembolization with resin
Richetta E; Pasquino M; Poli M; Cutaia C; Valero C; Tabone M; Paradisi BP; Pacilio M; Pellerito RE; Stasi M
Phys Med; 2019 Aug; 64():16-23. PubMed ID: 31515015
[TBL] [Abstract][Full Text] [Related]
6. Impact of image reconstruction method on dose distributions derived from
Hou X; Ma H; Esquinas PL; Uribe C; Tolhurst S; Bénard F; Liu D; Rahmim A; Celler A
Phys Med Biol; 2020 Nov; 65(21):215022. PubMed ID: 33245057
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the voxel-based approaches in radioembolization dosimetry with reDoseMC.
Kim TP; Enger SA
Med Phys; 2024 Jun; 51(6):4007-4027. PubMed ID: 38703394
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry of Y-90 Microspheres Utilizing Tc-99m SPECT and Y-90 PET.
Tafti BA; Padia SA
Semin Nucl Med; 2019 May; 49(3):211-217. PubMed ID: 30954187
[TBL] [Abstract][Full Text] [Related]
9. Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry.
D'Arienzo M; Filippi L; Chiaramida P; Chiacchiararelli L; Cianni R; Salvatori R; Scopinaro F; Bagni O
Ann Nucl Med; 2013 Aug; 27(7):676-80. PubMed ID: 23605058
[TBL] [Abstract][Full Text] [Related]
10. Retrospective SPECT/CT dosimetry following transarterial radioembolization.
Thompson BC; Dezarn WA
J Appl Clin Med Phys; 2021 Apr; 22(4):143-150. PubMed ID: 33710776
[TBL] [Abstract][Full Text] [Related]
11. Personalized Dosimetry for Liver Cancer Y-90 Radioembolization Using Computational Fluid Dynamics and Monte Carlo Simulation.
Roncali E; Taebi A; Foster C; Vu CT
Ann Biomed Eng; 2020 May; 48(5):1499-1510. PubMed ID: 32006268
[TBL] [Abstract][Full Text] [Related]
12. Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology.
Pacilio M; Ferrari M; Chiesa C; Lorenzon L; Mira M; Botta F; Becci D; Torres LA; Coca Perez M; Vergara Gil A; Basile C; Ljungberg M; Pani R; Cremonesi M
Med Phys; 2016 Jul; 43(7):4053. PubMed ID: 27370124
[TBL] [Abstract][Full Text] [Related]
13. Radioembolization Dosimetry with Total-Body
Costa G; Spencer B; Omidvari N; Foster C; Rusnak M; Hunt H; Caudle DT; Pillai RT; Vu CT; Roncali E
J Nucl Med; 2022 Jul; 63(7):1101-1107. PubMed ID: 34795015
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.
Wondergem M; Smits ML; Elschot M; de Jong HW; Verkooijen HM; van den Bosch MA; Nijsen JF; Lam MG
J Nucl Med; 2013 Aug; 54(8):1294-301. PubMed ID: 23749996
[TBL] [Abstract][Full Text] [Related]
15. Characterization of
Balagopal A; Kappadath SC
Med Phys; 2018 Feb; 45(2):875-883. PubMed ID: 29172243
[TBL] [Abstract][Full Text] [Related]
16.
Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS
Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165
[TBL] [Abstract][Full Text] [Related]
17. The impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization.
Tapp KN; Lea WB; Johnson MS; Tann M; Fletcher JW; Hutchins GD
J Nucl Med; 2014 Sep; 55(9):1452-8. PubMed ID: 24982437
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Tumor Control in
Dewaraja YK; Devasia T; Kaza RK; Mikell JK; Owen D; Roberson PL; Schipper MJ
J Nucl Med; 2020 Jan; 61(1):104-111. PubMed ID: 31147404
[TBL] [Abstract][Full Text] [Related]
19. Comparison of PMT-based TF64 and SiPM-based Vereos PET/CT systems for
Trotta N; Collette B; Mathey C; Vierasu I; Bucalau AM; Verset G; Moreno-Reyes R; Goldman S
Med Phys; 2022 Dec; 49(12):7567-7582. PubMed ID: 35894818
[TBL] [Abstract][Full Text] [Related]
20. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
